Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

naltrexone

Associated Studies:

Division Study Number Title Investigator(s) Release Date
CTN NIDA-CTN-0069 Opioid Use Disorder in the Emergency Department (ED-HEALTH) David A. Fiellin, M.D., Gail D'Onofrio, M.D., M.S.
CTN NIDA-CTN-0097 Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone (SWIFT) Adam Bisaga, M.D., Edward V. Nunes, M.D.
CTN NIDA-CTN-0079 Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT) John Rotrosen, M.D., Kathryn Hawk, M.D., M.H.S., Ryan McCormack, M.D.
CTN NIDA-CTN-0095A2 Reducing Stigma toward People with Opioid Use Disorder among Primary Care Clinicians Stephanie Hooker, Ph.D., M.P.H., Rebecca Rossom, M.D., M.S., A. Lauren Crain, Ph.D., Gavin Bart, Ph.D., M.D.
CTN NIDA-CTN-0055 Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES) P. Todd Korthuis, MD
CTN NIDA-CTN-0067 Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up P. Todd Korthuis, MD
CTN NIDA-CTN-0068 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) Madhukar H. Trivedi, M.D.
CTN NIDA-CTN-0054 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT) Walter Ling, M.D.
CTN NIDA-CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment John Rotrosen, M.D.
CTN NIDA-CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB) Walter Ling, M.D.
Subscribe to naltrexone